LOX-1 as a biological marker and therapeutic target in cardiovascular pathology (literature review)
Cardiovascular diseases (CVD) are a global medical, social and economic problem. Currently, the search and study of new biological markers that can provide early diagnosis of CVD, serve as a laboratory tool for evaluating the effectiveness of treatment or be used as prognostic markers and criteria f...
Saved in:
Main Authors: | Amina M. Alieva (Author), Irina E. Baykova (Author), Elena V. Reznik (Author), Natalia V. Teplova (Author), Ramiz K. Valiev (Author), Malika Kh. Gyzyeva (Author), Albina B. Sultangalieva (Author), Irina A. Kotikova (Author), Natalia A. Novikova (Author), Sergey A. Korvyakov (Author), Igor G. Nikitin (Author) |
---|---|
Format: | Book |
Published: |
ZAO "Consilium Medicum",
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fibroblast growth factor 21 (FGF21): diagnostic, prognostic and therapeutic aspects in heart failure. A review
by: Amina M. Alieva, et al.
Published: (2024) -
Endocan is a key player in cardiovascular disease: A review
by: Amina M. Alieva, et al.
Published: (2023) -
The role of interleukin-6 in the development of cardiovascular diseases: A review
by: Amina M. Alieva, et al.
Published: (2023) -
Catestanin - a promising biological marker for heart failure: A review
by: Amina M. Alieva, et al.
Published: (2022) -
Pentraxin-3 - a promising biological marker in heart failure: literature review
by: Amina M. Alieva, et al.
Published: (2022)